返回
ENvue Medical, Inc.（NAOV）价格
NAOV 股价走势图
NAOV 财务
ENvue Medical, Inc.
$1.31
-10.27%
$-0.14
收盘价：Jan 20, 16:00:00 GMT-5
$1.31
0%
$0
盘后：Jan 20, 20:00:00 GMT-5
关键数据
前收盘价
$1.46
开盘价
$1.41
当日区间
$1.1 - $1.44
52周范围
$1.31 - $162.5
交易量
666.9K
平均成交量
78.7K
每股收益（TTM）
-51.81
股息收益率
--
市值
$1.4M
什么是 NanoVibronix, Inc.？
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The firm's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
